抑郁初始严重程度与认知行为疗法疗效:安慰剂对照试验的个体参与者数据荟萃分析
该研究基于5项随机对照试验的个体参与者数据(n=509),采用混合模型荟萃分析,比较面对面个体或团体认知行为疗法(CBT)与药丸安慰剂在成人重度抑郁中的疗效。结果显示,CBT与安慰剂在汉密尔顿抑郁量表变化上的差异不受基线严重程度影响(交互P=0.43),总体标准化均数差为-0.22(95%CI -0.42至-0.02,P=0.03)。结论认为,不同基线严重程度的重度抑郁患者均可从CBT中获得相似获益。
要点
- CBT与安慰剂疗效差异不受抑郁基线严重程度影响(交互P=0.43)。
- 总体CBT优于安慰剂的标准化均数差为-0.22(95%CI -0.42至-0.02,P=0.03)。
- 重度抑郁患者在不同基线严重程度下均可期望从CBT中获得相似获益。
核心结论
- 在成人重度抑郁中,CBT与药丸安慰剂在抑郁症状变化上的差异不受基线严重程度影响。
- 总体而言,CBT优于安慰剂,标准化均数差为-0.22(95%CI -0.42至-0.02,P=0.03)。
研究设计与样本
- 系统综述与个体参与者数据荟萃分析,纳入5项随机对照试验,共509例成人重度抑郁患者。
- CBT为面对面个体或团体格式,对照为药丸安慰剂;采用混合模型,试验效应为随机效应,多重插补处理缺失数据。
主要发现
- CBT与安慰剂在汉密尔顿抑郁量表变化上的差异与基线严重程度的交互作用不显著(P=0.43)。
- 移除不显著的交互项后,CBT与安慰剂的标准化均数差为-0.22(95%CI -0.42至-0.02,P=0.03,I2=0%)。
关键数值与推荐
- 基线严重程度与治疗组别的交互作用P=0.43,表明疗效差异不随基线严重程度改变。
- CBT与安慰剂的总体标准化均数差为-0.22(95%CI -0.42至-0.02,P=0.03,I2=0%)。
临床怎么用
- 临床决策时,不应仅因抑郁基线严重程度高而排除CBT,患者在不同严重程度下均可期望相似获益。
- 该结果有助于患者与临床医生进行个体化治疗决策,权衡CBT与安慰剂对照证据。
局限性
- 仅纳入5项随机对照试验,样本量有限(n=509)。
- 研究比较CBT与药丸安慰剂,未直接比较CBT与活性药物或其他心理治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundThe influence of baseline severity has been examined for antidepressant medications but has not been studied properly for cognitive-behavioural therapy (CBT) in comparison with pill placebo.AimsTo synthesise evidence regarding the influence of initial severity on efficacy of CBT from all randomised controlled trials (RCTs) in which CBT, in face-to-face individual or group format, was compared with pill-placebo control in adults with major depression.MethodA systematic review and an individual-participant data meta-analysis using mixed models that included trial effects as random effects. We used multiple imputation to handle missing data.ResultsWe identified five RCTs, and we were given access to individual-level data (n = 509) for all five. The analyses revealed that the difference in changes in Hamilton Rating Scale for Depression between CBT and pill placebo was not influenced by baseline severity (interaction P = 0.43). Removing the non-significant interaction term from the model, the difference between CBT and pill placebo was a standardised mean difference of -0.22 (95% CI -0.42 to -0.02, P = 0.03, I2 = 0%).ConclusionsPatients suffering from major depression can expect as much benefit from CBT across the wide range of baseline severity. This finding can help inform individualised treatment decisions by patients and their clinicians.
引用
- Furukawa TA, Weitz ES, Tanaka S, et al. Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials. Br J Psychiatry. 2017. PMID: 28104735. doi:10.1192/bjp.bp.116.187773
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。